Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

NCT07487168 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Peritoneal Carcinomatosis

Interventions

DRUG: Mitomycin C (MMC)
DEVICE: Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC)

Sponsor

H. Lee Moffitt Cancer Center and Research Institute